Bedaquiline Roll-out Evidence in Contacts and People Living With HIV to Prevent TB

NCT06568484 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

RECRUITING

Status

2530

Enrollment

OTHER

Sponsor class

Conditions

Tuberculosis, Latent

Interventions

DRUG: Bedaquiline
COMBINATION_PRODUCT: Isoniazid, rifapentine
DRUG: Levofloxacin

Sponsor

Johns Hopkins University

Collaborators

Elizabeth Glaser Pediatric AIDS Foundation
US Department of State